Bronchoscopy Market Updates

Global Bronchoscopy Market size was valued at USD 2.68 Billion in 2023 and is poised to grow from USD 2.87 Billion in 2024 to USD 4.96 Billion by 2032, growing at a CAGR of 7.1% during the forecast period (2025-2032).

Bronchoscopy providers should focus on raising more awareness regarding respiratory diseases to maximize their sales potential. Investing in the R&D of novel disposable bronchoscopy equipment is also a key opportunity for companies as per this global bronchoscopy market analysis. 'Olympus Corporation', 'Karl Storz', 'Fujifilm Holdings Corporation', 'Ambu A/S', 'Boston Scientific Corporation', 'Medtronic', 'Johnson & Johnson', 'Hoyo Corporation', 'Richard Wolf GmbH', 'Cook Medical'

Bronchoscopy is favored for being a minimally invasive, low-risk diagnostic and therapeutic tool. It provides real-time visualization of airways, enabling tissue sampling, foreign body removal, and stent placement without large incisions. Growing geriatric population and their preference for minimally invasive surgeries owing to the high incidence of comorbidities are also helping make this a key driver for the global bronchoscopy market growth.

Rise of Robotic-Assisted Bronchoscopy (RAB): Robotic-assisted bronchoscopy is revolutionizing pulmonary diagnostics by improving precision and access to small, peripheral lung nodules. Robotic bronchoscopy equipment offers superior maneuverability and stability as compared to traditional equipment. These systems enhance diagnostic yield, reduce complications, and increase physician confidence. Growing demand for early lung cancer detection and minimally invasive approaches is accelerating RAB adoption and making it a mainstream bronchoscopy market trend.

Why is the Adoption of Bronchoscopy High in North America?